肥胖和糖尿病研究相关试剂
脂肪因子,褐色脂肪因子和肌肉因子,
IL-33&免疫代谢,血管生成素-2和肥胖,
白色脂肪褐变因子,AMPK,PARR和其他代谢调节剂
◆用于脂肪因子测定的 标准ELISA试剂盒
● 结果重复性好,批间和批内差异低!
● 高灵敏度!
● 检测样本种类丰富(如血清,血浆,上清液,尿液)!
● 许多产品均由相应的参考文献支持!
Adiponectin (human) ELISA Kit | |
Nampt (Visfatin/PBEF) (human) ELISA Kit | |
Progranulin (human) ELISA Kit | |
RBP4 (human) ELISA Kit (Quantitative) | |
Resistin (human) ELISA Kit | |
Zinc-α-2-glycoprotein (human) TurboELISA Kit |
◆IL-33&代谢平衡/免疫代谢
高活性IL-33蛋白
IL-33 (oxidation resistant) (human) (rec.) (untagged) | |
IL-33 (oxidation resistant) (human) (rec.) (His) |
在体内激活先天淋巴细胞2(ILC 2)。适用于人和小鼠。
IL - 33(oxidation resistant)(human)(rec.)(Untagged)( AG-40B-0160 )对体内先天淋巴细胞2(ILC 2)起激活作用。
方法:用PBS(图A)或IL-33(抗氧化)(人)(重组)(未标记)( AG-40B-0160 )(图B)每天注射C57BL / 6小鼠3天(每只小鼠0.4μg),在第4天,将来自骨髓的细胞染色并通过流式细胞仪分析,结果显示了天然淋巴细胞(门控为阴性对照,CD127阳性细胞)上ST2和KLRG1的水平。
Picture courtesy of Dr G.Verdeil / Dr S. Trabanelli (Camilla Jandus Group, Department of Fundamental Oncology, University of Lausanne).
IL-33阻断抗体蛋白
IL-33 (mouse), mAb (rec.) (blocking) (Bondy-1-1) | |
IL-33 (mouse), mAb (rec.) (blocking) (Bondy-1-1) (PF) |
抑制小鼠IL-33与ST2 / IL-1RAcP结合的IL-33特异性抗体
用于流式细胞仪的ST2特异性抗体
ST2 (human), pAb | AG-25B-0058 |
ST2 (human), pAb (ATTO 488) | AG-25B-0058YTD |
ST2 (human), pAb (ATTO 647N) | AG-25B-0058YTS |
用抗ST2(人),pAb(AG-25A-0058)检测内源性人ST2。
方法:将THP1细胞在4℃下使用抗ST2(人),pAb(1:100溶于PBS + 2%FCS)(图B)或单独的二抗(图A)染色1小时。 用抗兔IgG-APC(1:200)二抗显色,然后通过流式细胞仪分析结果。
◆强效的促血管生成素-2阻断抗体
最近的一项研究表明,血管生成素-2(angiopoietin-2,ANG-2)过度表达诱导了白色脂肪组织(WAT)中的促血管生成功能,防止高脂肪饮食(HFD)诱导的代谢挑战。使用中和抗体(anti-Angiopoietin-2, mAb (rec.) (blocking) (Angy-2-1) (AG-27B-0016PF))可以使血管生成素-2的水平降低,证实了其对内源性ANG – 2起有益作用。
LIT: Angiopoietin-2 in white adipose tissue improves metabolic homeostasis through enhanced angiogenesis: Y.A. An, et al.; Elife 29, 6 (2017)
Angiopoietin-2, mAb (rec.) (blocking) (Angy-2-1) | |
Angiopoietin-2, mAb (rec.) (blocking) (Angy-2-1) (PF) |
血管生成素-2 在体内与抗ANG - 2,mAb(rec.)(Blocking)(Angy - 2 - 1)(AG - 27 B - 0016 PF)作用可提高甘油三酯水平。
方法:对野生型C57BL / 6小鼠,其中对照组IgG(左),和抗ANG-2(克隆Angy-2-1)阻断抗体组(每周两次按4μg/g体重进行给药),在高脂肪饮食挑战实验后五周,分别对两组的甘油三酯水平进行代谢分析。
◆Asprosin –空腹诱导的Myokine 全新
白脂素是一种新型的空腹诱导蛋白激素,作用于肝脏并提高血浆葡萄糖水平。它是蛋白原纤蛋白-1的C端切割产物,由白色脂肪组织分泌,以cAMP为第二信使增加肝葡萄糖的生成,引起肝脏中蛋白激酶A的活化。降低白脂素水平可防止代谢综合征相关的高胰岛素症。
Asprosin(human) (rec.) (His) BULK Available | AG-40B-0174 |
各种褐变诱导剂
3-Aminoisobutyric acid (Contraction-induced Myokine) | |
CK2 Inhibitor 10 (CK2 Inhibitor) | |
CX-4945 . HCl (CK2 Inhibitor) | |
Miglitol (α-Glucosidase Inhibitor) | |
Papaverine . HCl (PDE10A Inhibitor) | |
PF-2545920 (PDE10A Inhibitor) | |
YM-254890 (Gαq Family Inhibitor) |
标准AMPK激活剂
AdipoRon . HCl (water soluble) | |
AICAR | |
Compound 112254 . HCl (water soluble) | |
MOTS-c (human) |
标准PPAR激动剂
Amorfrutin B (PPARγ Agonist) | |
Astaxanthin (PPARα Agonist) | |
Ciglitazone (PPARγ Agonist) | |
GW501516 (PPARδ Agonist) | |
Pioglitazone (PPARγ Agonist) | |
Pseudolaric acid B (PPARα Agonist) | |
Rosiglitazone . maleate (PPARγ Agonist) | |
Troglitazone (PPARγ Agonist) |
全新代谢研究相关试剂
Withaferin A (Leptin Sensitizer) | |
Celastrol (Leptin Sensitizer) | |
Shikonin (PKM2/Glycolysis Inhibitor) | |
N-Acetyl-D-glucosamine (Hexokinase Inhibitor) | |
GW311616A . HCl (Neutrophil Elastase Inhibitor) | |
Niclosamide (Increases Energy Expenditure) | |
Indole-3-carbinol (AhR Agonist/Microbiota) | |
trans-Indole-3-acrylic acid (Intestinal Barrier Homeostasis) |
◆产品列表
产品编号 | 产品名称 | 规格 |
Adiponectin (human) ELISA Kit | 96 wells | |
Adiponectin (human) ELISA Kit | 2×96 wells | |
Adiponectin (human) ELISA Kit (Penta Plex) | 5×96 wells | |
Nampt (Visfatin/PBEF) (human) ELISA Kit | 96 wells | |
Nampt (Visfatin/PBEF) (human) ELISA Kit | 2×96 wells | |
Nampt (Visfatin/PBEF) (human) ELISA Kit (Penta Plex) (人) ELISA 试剂盒 (5盒) | 5×96 wells | |
Progranulin (human) ELISA Kit | 96 wells | |
Progranulin (human) ELISA Kit | 2×96 wells | |
Progranulin (human) ELISA Kit (Penta Plex) | 5×96 wells | |
RBP4 (human) ELISA Kit (Quantitative) | 96 wells | |
RBP4 (human) ELISA Kit (Quantitative) | 2×96 wells | |
RBP4 (human) ELISA Kit (Quantitative) (Penta Plex) | 5×96 wells | |
Resistin (human) ELISA Kit | 96 wells | |
Resistin (human) ELISA Kit | 2×96 wells | |
Zinc-alpha-2-glycoprotein (human) TurboELISA Kit | 1 kit | |
IL-33 (oxidation resistant) (human) (rec.) (untagged) | 10μg | |
IL-33 (oxidation resistant) (human) (rec.) (untagged) | 100μg | |
IL-33 (oxidation resistant) (human) (rec.) (His) | 10μg | |
IL-33 (oxidation resistant) (human) (rec.) (His) | 100μg | |
anti-IL-33 (mouse), mAb (rec.) (blocking) (Bondy-1-1) | 100μg | |
anti-IL-33 (mouse), mAb (rec.) (blocking) (Bondy-1-1) (preservative free) | 100μg | |
anti-IL-33 (mouse), mAb (rec.) (blocking) (Bondy-1-1) (preservative free) | 500μg | |
anti-IL-33 (mouse), mAb (rec.) (blocking) (Bondy-1-1) (preservative free) | 1mg | |
anti-IL-33 (mouse), mAb (rec.) (blocking) (Bondy-1-1) (preservative free) | 100μg | |
anti-IL-33 (mouse), mAb (rec.) (blocking) (Bondy-1-1) (preservative free) | 500μg | |
anti-IL-33 (mouse), mAb (rec.) (blocking) (Bondy-1-1) (preservative free) | 1mg | |
anti-Angiopoietin-2, mAb (rec.) (blocking) (Angy-2-1) | 100μg | |
anti-Angiopoietin-2, mAb (rec.) (blocking) (Angy-2-1) (preservative free) | 100μg | |
anti-Angiopoietin-2, mAb (rec.) (blocking) (Angy-2-1) (preservative free) | 500μg | |
anti-Angiopoietin-2, mAb (rec.) (blocking) (Angy-2-1) (preservative free) | 1mg | |
anti-Angiopoietin-2, mAb (rec.) (blocking) (Angy-2-1) (preservative free) | 100μg | |
anti-Angiopoietin-2, mAb (rec.) (blocking) (Angy-2-1) (preservative free) | 500μg | |
anti-Angiopoietin-2, mAb (rec.) (blocking) (Angy-2-1) (preservative free) | 1mg | |
Asprosin (human) (rec.) (His) | 10μg | |
Asprosin (human) (rec.) (His) | 3×10μg | |
Asprosin (human) (rec.) (His) | 100μg | |
3-Aminoisobutyric acid | 250mg | |
3-Aminoisobutyric acid | 1g | |
CK2 Inhibitor 10 | 1mg | |
CK2 Inhibitor 10 | 5mg | |
CX-4945 . hydrochloride | 1mg | |
CX-4945 . hydrochloride | 5mg | |
CX-4945 . hydrochloride | 25mg | |
Miglitol | 10mg | |
Miglitol | 50mg | |
Papaverine . hydrochloride | 1g | |
Papaverine . hydrochloride | 5g | |
PF-2545920 | 1mg | |
PF-2545920 | 5mg | |
PF-2545920 | 25mg | |
YM-254890 | 500μg | |
YM-254890 | 1mg | |
AdipoRon . hydrochloride (water soluble) | 10mg | |
AdipoRon . hydrochloride (water soluble) | 50mg | |
AICAR | 10mg | |
AICAR | 50mg | |
AICAR | 100mg | |
Compound 112254 . hydrochloride (water soluble) | 10mg | |
Compound 112254 . hydrochloride (water soluble) | 50mg | |
MOTS-c (human) | 1mg | |
MOTS-c (human) | 5mg | |
Amorfrutin B | 500μg | |
Astaxanthin | 5mg | |
Astaxanthin | 25mg | |
Ciglitazone | 1mg | |
Ciglitazone | 5mg | |
Ciglitazone | 25mg | |
GW501516 | 1mg | |
GW501516 | 5mg | |
GW501516 | 25mg | |
Pioglitazone | 1mg | |
Pioglitazone | 25mg | |
Pioglitazone | 5mg | |
Pseudolaric acid B | 100μg | |
Pseudolaric acid B | 1mg | |
Rosiglitazone . maleate | 25mg | |
Rosiglitazone . maleate | 100mg | |
Rosiglitazone . maleate | 1g | |
Troglitazone | 5mg | |
Troglitazone | 25mg | |
Withaferin A | 1mg | |
Withaferin A | 5mg | |
Withaferin A | 10mg | |
Celastrol | 5mg | |
Celastrol | 10mg | |
Celastrol | 50mg | |
Shikonin | 10mg | |
Shikonin | 50mg | |
N-Acetyl-D-glucosamine | 250mg | |
N-Acetyl-D-glucosamine | 1g | |
N-Acetyl-D-glucosamine | 5g | |
GW311616A . hydrochloride | 1mg | |
GW311616A . hydrochloride | 5mg | |
GW311616A . hydrochloride | 25mg | |
Niclosamide | 100mg | |
Niclosamide | 1g | |
Indole-3-carbinol | 500mg | |
Indole-3-carbinol | 5g | |
trans-Indole-3-acrylic acid | 250mg | |
trans-Indole-3-acrylic acid | 1g |
免责声明 |
1. 本公司密切关注本网站发布的内容,但不保证发布内容的准确性、完整性、可靠性和最新性等。 2. 本公司不保证使用本网站期间不会出现故障或计算机病毒污染的风险。 3. 无论何种原因,使用本网站时给用户或第三方造成的任何不利或损害,本公司概不负责。此外,对于用户与其他用户或第三方之间因本网站发生的任何交易、通讯 3. 或纠纷,本公司概不负责。 4. 本网站可提供的所有产品和服务均不得用于人体或动物的临床诊断或治疗,仅可用于科研等非医疗目的。如任何用户将本网站提供的产品和服务用于临床诊断或治 4. 疗,以及其他特定的用途或行为,本公司概不保证其安全性和有效性,并且不负任何相关的法律责任。 |